Literature DB >> 24265912

Complete republication: Epidemiology of tuberculosis in the EU/EEA in 2010 - Monitoring the progress towards tuberculosis elimination.

A Sandgren1, V Hollo, E Huitric, C Ködmön.   

Abstract

The 2012 combined tuberculosis (TB) surveillance and monitoring report for the European Union and European Economic Area identifies a mean annual decline in TB notification rate by 4.4% from 2006 to 2010. Culture confirmation for new pulmonary cases and drug susceptibility testing have increased to 65.6% and 70.8%, but remain under their targets of 80% and 100%, respectively. Reporting of treatment outcome and coinfection with human immunodeficiency virus also remain suboptimal. Strengthened control practices are needed to allow progress towards TB elimination.

Entities:  

Keywords:  tuberculosis, population surveillance, bacterial, epidemiology, disease notification, drug resistance. European Union, humans

Year:  2012        PMID: 24265912      PMCID: PMC3832065          DOI: 10.1556/EuJMI.2.2012.4.8

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  4 in total

1.  The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.

Authors:  F A Drobniewski; V Nikolayevskyy; S Hoffner; O Pogoryelova; D Manissero; A J Ozin
Journal:  Euro Surveill       Date:  2008-03-18

2.  Marking 15 years of efforts towards a comprehensive European TB surveillance system: the epidemiological situation of TB in the EU/EEA in 2009.

Authors:  V Hollo; P Zucs; C Ködmön; A Sandgren; D Manissero
Journal:  Euro Surveill       Date:  2011-03-24

Review 3.  European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group.

Authors:  J F Broekmans; G B Migliori; H L Rieder; J Lees; P Ruutu; R Loddenkemper; M C Raviglione
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

4.  Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009.

Authors:  A Sandgren; V Hollo; C Quinten; D Manissero
Journal:  Euro Surveill       Date:  2011-03-24
  4 in total
  3 in total

1.  Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis.

Authors:  Vanina Meyssonnier; Thuy Van Bui; Nicolas Veziris; Vincent Jarlier; Jérôme Robert
Journal:  BMC Infect Dis       Date:  2014-01-10       Impact factor: 3.090

2.  Estimating the annual risk of tuberculosis infection and disease in southeast of iran using the bayesian mixture method.

Authors:  Ali Akbar Haghdoost; Mahdi Afshari; Mohammad Reza Baneshi; Mohammad Mehdi Gouya; Mahshid Nasehi; Mahtab Movahednia
Journal:  Iran Red Crescent Med J       Date:  2014-09-05       Impact factor: 0.611

3.  Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.

Authors:  Leonela Villegas; Larissa Otero; Timothy R Sterling; Moises A Huaman; Patrick Van der Stuyft; Eduardo Gotuzzo; Carlos Seas
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.